Article Sidebar

PDF
Date Published: 17/02/2023
Abstract Views: 549
Views PDF: 360
DOI: https://doi.org/10.51298/vmj.v520i2.4189
Issue
Vol. 520 No. 2 (2022)
Section
Các bài báo
How to Cite
Nguyễn, T. H., & Vũ, T. T. (2023). MEDICATION PATTERNS AND LUNG FUNCTION IN ASTHMA PATIENTS: AN OBSERVATIONAL STUDY. Vietnam Medical Journal, 520(2). https://doi.org/10.51298/vmj.v520i2.4189

MEDICATION PATTERNS AND LUNG FUNCTION IN ASTHMA PATIENTS: AN OBSERVATIONAL STUDY

Thu Hằng Nguyễn1,, Thị Thủy Vũ2
1 Vinh medical university
2 Vinh medical university hospital

Main Article Content

Abstract

Asthma is a disease characterized by chronic inflammation of the bronchial mucosa. The asthma management cycle for personalized asthma care consists of review, assessment and adjustment. An observational study was conducted on asthma outpatients with the aim of providing practical data of  medication use. Out of 106 visits, 100% of patients were prescribed LABA-ICS. Salmeterol, formoterol, fluticasone and budesonide were prescribed most, accounted for 63,20%; 38,68%; 63,20% and 38,68% respectively. Respiratory functions did not change statistically during one year of treatment. The study will contribute to improving the effectiveness of asthma treatment and control.

Article Details

Keywords

asthma, LABA, ICS, FEV1, FVC, PEF

References

1. Bộ Y Tế (2020), “Hướng dẫn chẩn đoán và điều trị hen phế quản người lớn và trẻ em  12 tuổi”
2. WHO, “Asthma”, https://www.who.int/news-room/fact-sheets/detail/asthma, truy cập 31/07/2022.
3. Pandey A, Tripathi P, Pandey RD (2010), “Prescription pattern in asthma therapy at Gorakhpur hospitals”, Lung India, 27(1):pp8-10.
4. GINA (2022), “Global Strategy for asthma management and prevention”.
5. Undela K, et al (2021), “Macrolides versus placebo for chronic asthma”, Cochrane Database of Systematic Reviews 2021, 11. doi: 10.1002/14651858.CD002997.pub5
6. An TJ, et al (2018), “Effects of Macrolide and Corticosteroid in Neutrophilic Asthma Mouse Model”, Tuberc Respir Dis, 81(1), pp.80-87. doi: 10.4046/trd.2017.0108.
7. FDA (2020), Singulair (montelukast) and All Montelukast Generics: Strengthened Boxed Warning - Due to Restricting Use for Allergic Rhinitis.
8. Hill B (2019), “Measuring peak expiratory flow in adults with asthma”, Br J Nurs. 25;28(14): pp.924-926. doi: 10.12968/bjon.2019.28.14.924.